Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 130 (4) , 692-697
- https://doi.org/10.1016/0002-8703(95)90065-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarctionThe American Journal of Cardiology, 1992
- Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)Journal of the American College of Cardiology, 1992
- Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin.Circulation Research, 1989
- Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.Circulation, 1989
- Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.Circulation, 1988
- Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.Circulation, 1988
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rateThe American Journal of Cardiology, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Demonstration of a fast-acting inhibitor of plasminogen activators in human plasmaBlood, 1984